Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02461459 · ClinicalTrials.gov registry record

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

A clinical trial of Intellectual Disability and Tuberous Sclerosis, sponsored by Boston Children's Hospital.

Active
Registry status
205
Enrollment target
6
Study locations

NCT02461459 is a study of Intellectual Disability and Tuberous Sclerosis that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 205 participants, below the 346-participant average among 26 other Intellectual Disability trials with a reported enrollment target (41% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02461459, a study of Intellectual Disability and Tuberous Sclerosis, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
205 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to characterize the developmental phenotype of ASD and ID and to identify biomarkers using advanced MRI methodology and electrophysiological biomarkers of synaptic function and connectivity predictive of ASD and ID presence and severity in patients with TSC. In addition, this study will be establishing infrastructure for the collection and storage of human bio-specimens, including genetic material, from TSC patients and their family members with ASD.

Conditions Studied

Intellectual Disability Tuberous Sclerosis Autism Disorder

Study Locations (6)

California

  • University of California at Los Angeles - Los Angeles
  • Stanford University - Palo Alto

Alabama

  • University of Alabama at Birmingham - Birmingham

Massachusetts

  • Boston Children's Hospital - Boston

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Texas

  • University of Texas at Houston - Houston

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2015-05
Est. Completion 2026-12

Sponsor

Boston Children's Hospital

462 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02461459

The ClinicalTrials.gov registry entry for NCT02461459 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 346-participant average among 26 other Intellectual Disability trials with a reported enrollment target (41% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Intellectual Disability appearing as the primary indexed condition, and to 0 interventions.

NCT02461459 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Alabama, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02461459 about?

NCT02461459 is a clinical study titled "Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)". The purpose of this study is to characterize the developmental phenotype of ASD and ID and to identify biomarkers using advanced MRI methodology and electrophysiological biomarkers of synaptic function and connectivity predictive of ASD and ID presence and severity in patients with TSC. In addition,...

What is the current status of trial NCT02461459?

This trial is currently active not recruiting. The enrollment target is 205 participants. The study started on 2015-05. Estimated completion is 2026-12.

What conditions does trial NCT02461459 study?

This clinical trial studies the following conditions: Intellectual Disability, Tuberous Sclerosis, Autism Disorder.

Who is sponsoring clinical trial NCT02461459?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02461459 being conducted?

This trial has 6 study locations across Alabama, California, Massachusetts, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intellectual Disability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Intellectual Disability

All registered trials for this condition

Tuberous Sclerosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.